Calmare Therapeutics Stock Fundamentals
| CTTCDelisted Stock | USD 0.0001 0.00 0.00% |
Calmare Therapeutics fundamentals help investors to digest information that contributes to Calmare Therapeutics' financial success or failures. It also enables traders to predict the movement of Calmare Stock. The fundamental analysis module provides a way to measure Calmare Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Calmare Therapeutics stock.
Calmare |
Calmare Therapeutics Company Shares Outstanding Analysis
Calmare Therapeutics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Calmare Therapeutics Shares Outstanding | 30.38 M |
Most of Calmare Therapeutics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Calmare Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Calmare Therapeutics has 30.38 M of shares currently outstending. This is 83.17% lower than that of the Health Care Equipment & Supplies sector and 82.64% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 94.69% higher than that of the company.
Calmare Therapeutics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Calmare Therapeutics's current stock value. Our valuation model uses many indicators to compare Calmare Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Calmare Therapeutics competition to find correlations between indicators driving Calmare Therapeutics's intrinsic value. More Info.Calmare Therapeutics is rated third in return on asset category among its peers. It is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Calmare Therapeutics' earnings, one of the primary drivers of an investment's value.Calmare Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Calmare Therapeutics' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Calmare Therapeutics could also be used in its relative valuation, which is a method of valuing Calmare Therapeutics by comparing valuation metrics of similar companies.Calmare Therapeutics is currently under evaluation in shares outstanding category among its peers.
Calmare Fundamentals
| Return On Asset | -0.38 | |||
| Operating Margin | (2.14) % | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 30.38 M | |||
| Shares Owned By Institutions | 6.92 % | |||
| Number Of Shares Shorted | 212.63 K | |||
| Price To Earning | (0.68) X | |||
| Price To Sales | 4.82 X | |||
| Revenue | 1.17 M | |||
| Gross Profit | 771.48 K | |||
| EBITDA | (2.43 M) | |||
| Net Income | (3.83 M) | |||
| Cash And Equivalents | 12.55 K | |||
| Current Ratio | 0.22 X | |||
| Book Value Per Share | (0.48) X | |||
| Cash Flow From Operations | (1.24 M) | |||
| Short Ratio | 3.99 X | |||
| Earnings Per Share | (0.13) X | |||
| Target Price | 0.79 | |||
| Beta | 0.57 | |||
| Market Capitalization | 11.09 K | |||
| Total Asset | 3.88 M | |||
| Retained Earnings | (62.01 M) | |||
| Working Capital | (12.68 M) | |||
| Current Asset | 3.96 M | |||
| Current Liabilities | 16.64 M | |||
| Z Score | -24.6 | |||
| Net Asset | 3.88 M |
About Calmare Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Calmare Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Calmare Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Calmare Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut. Calmare Therapeutics operates under Medical Devices classification in the United States and is traded on NYSEMKT Exchange. It employs 7 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Calmare Stock
If you are still planning to invest in Calmare Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calmare Therapeutics' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |